To avoid any doubt: I did not question your experience … but you questioned JT.
That doesn’t correspond to reality.
How anybody could think that JT said what he said without any background / info?
As a new drug, we are starting off with the already having pretty good managed-care coverage, considerable portion of our prescriptions currently are off label and the approval rate for managed-care is just a shade under 80%, little over 90% of adult lives on Medicare Part D covered by insurance predominantly tier 2, predominantly unrestricted, and about 80% of lives on commercial insurance covered by insurance. So, again predominantly tier 2, predominantly unrestricted.
It is the reality … which isn't equal with your experience … but nothing is wrong with it.